Norman Broadbent PLC Conversion Of Outstanding Convertible Loan Notes (1856S)
02 Noviembre 2023 - 2:43AM
UK Regulatory
TIDMNBB
RNS Number : 1856S
Norman Broadbent PLC
02 November 2023
THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT
QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE
PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014
AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION
(WITHDRAWAL) ACT 2018.
2 November 2023
Norman Broadbent plc
("Norman Broadbent" or the "Company")
conversion and EARLY Redemption of OUTSTANDING convertible loan
notes
and
Total voting rights
Conversion and early redemption of outstanding Convertible Loan
Notes (the "CLNs")
Norman Broadbent (AIM: NBB), a leading London quoted Executive
Search and Interim Management firm offering a diversified portfolio
of integrated Leadership Acquisition & Advisory Services, is
pleased to announce the conversion and early redemption of all
outstanding CLNs. The CLNs were issued to two holders in May 2022
with a value of GBP0.4 million, half of which was redeemed by the
Company in May 2023.
The Company has received conversion notices from both
noteholders and consequently has allotted 2,047,706 new ordinary
shares of 1p each (the "New Shares") at a conversion price of 7.0
pence per New Share for half the outstanding amount of the CLNs,
the repayment of all interest due and the redemption fee. The
remaining GBP100,000 of the CLNs has been redeemed.
Application will be made to the London Stock Exchange for
admission of the New Shares to trading on AIM ("Admission"). It is
expected that Admission will become effective and dealings will
commence in the New Shares on 10 November 2023. The New Shares will
rank pari passu with the existing ordinary shares of 1p each in the
Company (the "Ordinary Shares").
Total Voting Rights
Following Admission, the Company's issued share capital will
consist of 63,865,249 Ordinary Shares, none of which are held in
treasury. Accordingly, the figure of 63,865,249 may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change to their interest in the Company under the FCA's
Disclosure Guidance and Transparency Rules.
For further Information, please contact:
Norman Broadbent plc 020 7484 0000
Kevin Davidson, CEO
Mehr Malik, CFO
Shore Capital ( Nominated Adviser and Broker) 020 7408 4090
Tom Griffiths / Tom Knibbs (Corporate Advisory)
Henry Willcocks (Corporate Broking)
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCUPGGCGUPWURP
(END) Dow Jones Newswires
November 02, 2023 04:43 ET (08:43 GMT)
Norman Broadbent (LSE:NBB)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Norman Broadbent (LSE:NBB)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024